Dr James Allen Bullard, MD | |
4 Ohio St, Decorah, IA 52101-1516 | |
(563) 382-3603 | |
(563) 382-3606 |
Full Name | Dr James Allen Bullard |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 4 Ohio St, Decorah, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508183179 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 15529 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr James Allen Bullard, MD 4 Ohio St, Decorah, IA 52101-1516 Ph: (563) 382-3603 | Dr James Allen Bullard, MD 4 Ohio St, Decorah, IA 52101-1516 Ph: (563) 382-3603 |
News Archive
Those considering how to maintain a healthy weight during holiday festivities, or looking ahead to New Year's resolutions, may want to think twice before reaching for traditional staples like cookies or candy - or the car keys.
USAID's website features a page dedicated to World TB Day, which will be commemorated on March 24. The page lists information on upcoming events, as well as links to several reports, such as the FY2010 Report to Congress on the Global TB Context, stories, and features.
Welichem Biotech Inc. announces today the results of its substantial issuer bid, pursuant to which the Company offered to purchase for cancellation up to 23,529,411 of its issued and outstanding common shares ("Shares") at a purchase price of $0.85 per Share for an aggregate purchase price of up to $20 million (the "Offer"). The offer expired at 5:00 p.m. (Toronto time) on October 9, 2013.
The American Association of Clinical Endocrinologists (AACE), along with the rest of the medical community, has watched with concern the debate regarding usage of GlaxoSmithKline's rosiglitazone (Avandia) in diabetes and the question of whether it increases cardiovascular risk.
› Verified 5 days ago